Literature DB >> 11160710

Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain.

T Laskus1, L F Wang, M Radkowski, H Vargas, M Nowicki, J Wilkinson, J Rakela.   

Abstract

We have analyzed three cases of hepatitis C virus (HCV)-infected recipients who received blood from HCV-infected donors. Two recipients were exposed to two different HCV RNA-positive donors, and one was exposed to a single donor. All parental genomes from the actual infecting units of blood and the recipients were defined, and their presence in the follow-up serum samples was determined using sensitive strain-specific assays. The strain from one of the donors was found to predominate in all recipients' serum samples collected throughout the follow-up period of 10 to 30 months. In two recipients exposed to two infected donors, the strain from the second donor was occasionally found at very low level. However, the original recipients' strains were not detected. Our observations show that HCV-infected individuals can be superinfected with different strains, and this event may lead to eradication or suppression of the original infecting strain. Furthermore, our findings demonstrate that simultaneous exposure to multiple HCV strains may result in concomitant infection by more than one strain, although a single strain could rapidly establish its dominance. The results of the present study suggest the existence of competition among infecting HCV strains which determines the ultimate outcome of multiple HCV exposure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160710      PMCID: PMC114790          DOI: 10.1128/JVI.75.5.2059-2066.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors.

Authors:  T Laskus; L F Wang; J Rakela; H Vargas; A D Pinna; A C Tsamandas; A J Demetris; J Fung
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

2.  Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center.

Authors:  H E Vargas; L F Wang; T Laskus; A Poutous; R Lee; A Demetris; F Dodson; A Casavilla; J Fung; T Gayowski; N Singh; I Marino; J Rakela
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

Review 3.  Virus 'quasispecies': making a mountain out of a molehill?

Authors:  D B Smith; J McAllister; C Casino; P Simmonds
Journal:  J Gen Virol       Date:  1997-07       Impact factor: 3.891

4.  Hepatitis C virus genotypes in northern Italy: clinical and virological features.

Authors:  A Ravaggi; A Rossini; C Mazza; M Puoti; M G Marin; E Cariani
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

5.  Identification of numerous hepatitis C virus genotypes in Montreal, Canada.

Authors:  L Bernier; B Willems; G Delage; D G Murphy
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

6.  Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients.

Authors:  X Forns; M D Maluenda; F X López-Labrador; S Ampurdanès; E Olmedo; J Costa; P Simmonds; J M Sánchez-Tapias; M T Jimenez De Anta; J Rodés
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

7.  Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions.

Authors:  P Toniutto; M Pirisi; S G Tisminetzky; C Fabris; E Chinellato; M Gerotto; E Falleti; P Ferroni; T Lombardelli; E Bartoli; F Baralle
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

8.  Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.

Authors:  S Zeuzem; J M Schmidt; J H Lee; B Rüster; W K Roth
Journal:  Hepatology       Date:  1996-02       Impact factor: 17.425

9.  Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins.

Authors:  A M Prince; T Huima-Byron; T S Parker; D M Levine
Journal:  J Viral Hepat       Date:  1996-01       Impact factor: 3.728

10.  Hepatitis C virus genotypes in Belgian hemophiliacs.

Authors:  L Sheng; M Willems; K Peerlinck; J Vermylen; S H Yap
Journal:  J Med Virol       Date:  1995-02       Impact factor: 2.327

View more
  17 in total

Review 1.  The evolution of bovine viral diarrhea: a review.

Authors:  S Denise Goens
Journal:  Can Vet J       Date:  2002-12       Impact factor: 1.008

Review 2.  Vaccine-induced pathogen strain replacement: what are the mechanisms?

Authors:  Maia Martcheva; Benjamin M Bolker; Robert D Holt
Journal:  J R Soc Interface       Date:  2008-01-06       Impact factor: 4.118

Review 3.  Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

Authors:  Evan B Cunningham; Tanya L Applegate; Andrew R Lloyd; Gregory J Dore; Jason Grebely
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

4.  Infection of tick cells and bovine erythrocytes with one genotype of the intracellular ehrlichia Anaplasma marginale excludes infection with other genotypes.

Authors:  José de la Fuente; Jose C Garcia-Garcia; Edmour F Blouin; Jeremiah T Saliki; Katherine M Kocan
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

5.  Incident Hepatitis C Virus Genotype Distribution and Multiple Infection in Australian Prisons.

Authors:  Melanie R Walker; Hui Li; Suzy Teutsch; Brigid Betz-Stablein; Fabio Luciani; Andrew R Lloyd; Rowena A Bull
Journal:  J Clin Microbiol       Date:  2016-05-11       Impact factor: 5.948

6.  Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid.

Authors:  Tomasz Laskus; Marek Radkowski; Agnieszka Bednarska; Jeffrey Wilkinson; Debra Adair; Marek Nowicki; Georgia B Nikolopoulou; Hugo Vargas; Jorge Rakela
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  A viral protein mediates superinfection exclusion at the whole-organism level but is not required for exclusion at the cellular level.

Authors:  María Bergua; Mark P Zwart; Choaa El-Mohtar; Turksen Shilts; Santiago F Elena; Svetlana Y Folimonova
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

Review 8.  Human liver transplantation as a model to study hepatitis C virus pathogenesis.

Authors:  Michael G Hughes; Hugo R Rosen
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

9.  Evidence for lack of cross-genotype protection of CD4+ T cell responses during chronic hepatitis C virus infection.

Authors:  G C Harcourt; M Lucas; A J Godkin; M Kantzanou; R E Phillips; P Klenerman
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

10.  Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART).

Authors:  Tomasz Laskus; Jeffrey Wilkinson; Roksana Karim; Wendy Mack; Marek Radkowski; Marina deGiacomo; Jonathan Nasseri; Zhi Chen; Jiaao Xu; Andrea Kovacs
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.